A1 Journal article (refereed)
The Platform Development, Adherence and Efficacy to a Digital Brief Therapy for Insomnia (dBTI) During the COVID-19 Pandemic (2022)


Xingchang, L., Yuanhui, L., Rui, Y., Hämäläinen, T., Dai, L., Shuai, L., Chenxi, Z., Yan, X., Xian, L., & Bin, Z. (2022). The Platform Development, Adherence and Efficacy to a Digital Brief Therapy for Insomnia (dBTI) During the COVID-19 Pandemic. Methods, 205, 39-45. https://doi.org/10.1016/j.ymeth.2022.04.016


JYU authors or editors


Publication details

All authors or editors: Xingchang, Liu; Yuanhui, Li; Rui, Yan; Hämäläinen, Timo; Dai, Li; Shuai, Liu; Chenxi, Zhang; Yan, Xu; Xian, Luo; Bin, Zhang

Journal or series: Methods

ISSN: 1046-2023

eISSN: 1095-9130

Publication year: 2022

Publication date: 05/05/2022

Volume: 205

Pages range: 39-45

Publisher: Elsevier

Publication country: United States

Publication language: English

DOI: https://doi.org/10.1016/j.ymeth.2022.04.016

Persistent website address: https://doi.org/10.1016/j.ymeth.2022.04.016

Publication open access: Other way freely accessible online

Publication channel open access: Partially open access channel


Abstract

Brief therapy for insomnia (BTI) is a short-term cognitive behavioral therapy for insomnia. At present, there is no study combining BTI with digital technology. However, in the context of the outbreak of coronavirus disease 2019 (COVID-19), patients with acute insomnia may need an online treatment which can quickly improve insomnia symptoms. Our team built a digital BTI (dBTI) platform based on the WeChat mini program. This research provides a framework design and a course design of dBTI, and evaluates the system via recruiting participants suffering from acute insomnia in pandemic. What's more, it explores patients’ adherence, the efficiency of the system and their relationship. As the result demonstrates, 68% of participants have completed more than half of the course with medium to high adherence. Gender, pre-sleep arousal scale (PSAS) somatic score and insomnia severity index (ISI) score have affected participants’ adherence, and higher adherence has led to better improvement in the severity of insomnia and somatic pre-sleep arousal. It is proved that the platform we built is effective, which not only offers an entry point for the study of how to set up a dBTI platform, but also provides theoretical basis for its clinical application.


Keywords: insomnia; treatment methods; brief therapy; e-healthcare; mobile apps; unusual conditions; COVID-19

Free keywords: Digital Medicine; dBTI; Platform Development; WeChat Mini Program; Adherence


Contributing organizations


Ministry reporting: Yes

Reporting Year: 2022

Preliminary JUFO rating: 1


Last updated on 2022-27-10 at 15:01